Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-22 · accession 0001628280-24-006982 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-26 | 2024-02-22 | VIR | Pang Phillip | EVP, Chief Medical Off | S - Sale | $10.05 | -14.6K | 250.1K | -6% | -$146.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-22 | S | D | 14,568 | $10.05 | 250,111 | D | — | — |